Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Rang in Aktien #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Aktienkurs
$0.05124204
Marktkapitalisierung
$7.78M
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
-23.73%
Land
CH
Handel Addex Therapeutics Ltd (ADXN)

Kategorie

Aktien-Split-Historie für Addex Therapeutics Ltd (ADXN)
Die Aktie Addex Therapeutics Ltd (Symbol: ADXN) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 17, 2026 statt.
Eine ADXN-Aktie, die vor dem Aug 17, 2026 gekauft wurde, entspricht heute 0 ADXN-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE